Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer

Table 1 Chi-square test for clinicopathological factors and pathological response after neoadjuvant chemotherapy in GC patients

Factors	No. of patients (total, n = 203)			χ²	P
Factors	Total no. of rows	Pathological response (CAP 0, 1, 2)	No pathological response (CAP 3)	χ²	P
1. Age (years)
≥ 60	119	79	40	4.405	0.044
< 60	84	44	40
2. Sex
Male	155	94	61	0.001	0.977
Female	48	29	19
3. Smoking
Smokers	106	64	42	0.004	0.948
Non-smokers	97	59	38
4. Drinking
Drinkers	70	41	29	0.183	0.669
Non-drinkers	133	82	51
5. Smoking and drinking
Both	61	36	25	0.091	0.955
One of them	54	33	21
Neither	88	54	34
6. cT stage
T2	21	16	5	5.192	0.158
T3	73	47	26
T4a	101	57	44
T4b	8	3	5
7. cN stage
N-	61	38	23	0.106	0.745
N+	142	85	57
8. Tumor location
Upper	47	34	13	4.589	0.204
Middle	65	40	25
Lower	89	48	41
Whole	2	1	1
9. Pathological type
Well-differentiated or moderately differentiated	62	46	16	6.917	0.009
Poorly differentiated or signet-ring cell	141	77	64
10. Course
2	39	23	16	0.908	0.635
3	57	32	25
4	107	68	39
11. Weight change
No weight loss	113	75	38	3.567	0.059
Weight loss	90	48	42

ISSN: 1477-7819